The preclinical, small molecule program offers a potential first-in-class, oral, precision immunometabolic approach to modulating disease-driving immune cells
Deal includes upfront and milestone ...
MADRID, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Neinor Homes (“Neinor”) closed FY25 with standout operational and financial results. During FY25 and excluding the impact from acquiring a 79.2% stake in ...